Literature DB >> 6186990

Interferon-induced 56,000 Mr protein and its mRNA in human cells: molecular cloning and partial sequence of the cDNA.

J Chebath, G Merlin, R Metz, P Benech, M Revel.   

Abstract

Treatment of responsive cells by interferons (IFNs) induces within a few hours a rise in the concentration of several proteins and mRNAs. In order to characterize these IFN-induced mRNA species, we have cloned in E. coli the cDNA made from a 17-18S poly(A)+ RNA of human fibroblastoid cells (SV80) treated with IFN-beta. We describe here a pBR322 recombinant plasmid (C56) which contains a 400 bp cDNA insert corresponding to a 18S mRNA species newly induced by IFN. The C56 mRNA codes for a 56,000 dalton protein easily detectable by hybridization-translation experiments. The sequence of 66 of the carboxy-terminal amino-acids of the protein can be deduced from the cDNA sequence. IFNs-alpha, beta or gamma are able to activate the expression of this gene in human fibroblasts as well as lymphoblastoid cells. The mRNA is not detectable without IFN; it reaches maximum levels (0.1% of the total poly(A)+ RNA) within 4-8 hrs and decreases after 16 hrs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6186990      PMCID: PMC325791          DOI: 10.1093/nar/11.5.1213

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  42 in total

1.  Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Cancer Res       Date:  1968-07       Impact factor: 12.701

2.  Accumulation of newly synthesized mRNAs in response to human fibroblast (beta) interferon.

Authors:  R J Colonno
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

Review 3.  Mechanism of interferon action: progress toward its understanding.

Authors:  G C Sen
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1982

4.  Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells.

Authors:  M Fellous; U Nir; D Wallach; G Merlin; M Rubinstein; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

5.  Inhibition of interferon action by actinomycin.

Authors:  J Taylor
Journal:  Biochem Biophys Res Commun       Date:  1964       Impact factor: 3.575

6.  Preferential effect of gamma interferon on the synthesis of HLA antigens and their mRNAs in human cells.

Authors:  D Wallach; M Fellous; M Revel
Journal:  Nature       Date:  1982-10-28       Impact factor: 49.962

7.  Susceptibility of human diploid fibroblast strains to transformation by SV40 virus.

Authors:  G J Todaro; H Green; M R Swift
Journal:  Science       Date:  1966-09-09       Impact factor: 47.728

8.  Synthesis of human interferon beta 1 in Escherichia coli infected by a lambda phage recombinant containing a human genomic fragment.

Authors:  Y Mory; Y Chernajovsky; S I Feinstein; L Chen; U Nir; J Weissenbach; Y Malpiece; P Tiollais; D Marks; M Ladner; C Colby; M Revel
Journal:  Eur J Biochem       Date:  1981-11

9.  Induction of unique mRNAs by human interferons.

Authors:  R J Colonno; R H Pang
Journal:  J Biol Chem       Date:  1982-08-25       Impact factor: 5.157

10.  Modulation of tubulin mRNA levels by interferon in human lymphoblastoid cells.

Authors:  A Fellous; I Ginzburg; U Z Littauer
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  42 in total

1.  Regulation of synthesis and turnover of an interferon-inducible mRNA.

Authors:  J Kusari; G C Sen
Journal:  Mol Cell Biol       Date:  1986-06       Impact factor: 4.272

2.  Loss of (2'-5')oligoadenylate synthetase activity by production of antisense RNA results in lack of protection by interferon from viral infections.

Authors:  A De Benedetti; B A Pytel; C Baglioni
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

3.  Enhanced expression of interferon-regulated genes in the liver of patients with chronic hepatitis C virus infection: detection by suppression-subtractive hybridization.

Authors:  R Patzwahl; V Meier; G Ramadori; S Mihm
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Identification of interferon-modulated proliferation-related cDNA sequences.

Authors:  D A Kulesh; D R Clive; D S Zarlenga; J J Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

5.  Characterization of the interaction between the interferon-induced protein P56 and the Int6 protein encoded by a locus of insertion of the mouse mammary tumor virus.

Authors:  J Guo; G C Sen
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  Interferon-induced transcription of a major histocompatibility class I gene accompanies binding of inducible nuclear factors to the interferon consensus sequence.

Authors:  Y Shirayoshi; P A Burke; E Appella; K Ozato
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

7.  Transcription of interferon-stimulated genes is induced by adenovirus particles but is suppressed by E1A gene products.

Authors:  N Reich; R Pine; D Levy; J E Darnell
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

8.  Interferon alters the pattern of secreted proteins from Ehrlich ascites-tumour cells.

Authors:  S Tominaga; K Tominaga
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

9.  Interferon gamma-induced transcription of the high-affinity Fc receptor for IgG requires assembly of a complex that includes the 91-kDa subunit of transcription factor ISGF3.

Authors:  R N Pearse; R Feinman; K Shuai; J E Darnell; J V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

10.  A family of interferon-induced Mx-related mRNAs encodes cytoplasmic and nuclear proteins in rat cells.

Authors:  E Meier; J Fäh; M S Grob; R End; P Staeheli; O Haller
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.